Bessi Qorri

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Childhood Cancer

Metabolic Syndrome

Top Venues

Drug design, development and therapy

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

William W Harless, Beth Lewis, Bessi Qorri, Samar Abdulkhalek, Myron R Szewczuk
Novel Therapeutic Target Critical for SARS-CoV-2 Infectivity and Induction of the Cytokine Release Syndrome. Cells 12 (9) (2023)
William W Harless, Beth Lewis, Bessi Qorri, Samar Abdulkhalek, Myron R Szewczuk
Novel Therapeutic Target Critical for SARS-CoV-2 Infectivity and Induction of the Cytokine Release Syndrome. Cells 12 (9) (2023)
Bessi Qorri, Reza Bayat Mokhtari, William W Harless, Myron R Szewczuk
Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression. Cancers 14 (6) (2022)
Bessi Qorri, Reza Bayat Mokhtari, William W Harless, Myron R Szewczuk
Repositioning of Old Drugs for Novel Cancer Therapies: Continuous Therapeutic Perfusion of Aspirin and Oseltamivir Phosphate with Gemcitabine Treatment Disables Tumor Progression, Chemoresistance, and Metastases. Cancers 14 (15) (2022)
Reza Bayat Mokhtari, Bessi Qorri, Manpreet Sambi, Narges Baluch, Sushil Kumar, Bikul Das, Myron R Szewczuk, Herman Yeger, Hai-Ling Margaret Cheng
3D Multicellular Stem-Like Human Breast Tumor Spheroids Enhance Tumorigenicity of Orthotopic Xenografts in Athymic Nude Rat Model. Cancers 13 (11) (2021)
Reza Bayat Mokhtari, Manpreet Sambi, Bessi Qorri, Narges Baluch, Neda Ashayeri, Sushil Kumar, Hai-Ling Margaret Cheng, Herman Yeger, Bikul Das, Myron R Szewczuk
The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy. Cancers 13 (14) (2021)
Bessi Qorri, William Harless, Myron R Szewczuk
Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells. Drug design, development and therapy 14 (2020)
Manpreet Sambi, Vanessa Samuel, Bessi Qorri, Sabah Haq, Sergey V Burov, Elena Markvicheva, William Harless, Myron R Szewczuk
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer. Drug design, development and therapy 14 (2020)
Iryna Liauchonak, Bessi Qorri, Fady Dawoud, Yatin Riat, Myron R Szewczuk
Non-Nutritive Sweeteners and Their Implications on the Development of Metabolic Syndrome. Nutrients 11 (3) (2019)
Justin Jain, Bessi Qorri, Myron R Szewczuk
The crucial role of primary care providers in the long-term follow-up of adult survivors of childhood cancer. Cancer management and research 11 (2019)
Iryna Liauchonak, Fady Dawoud, Yatin Riat, Bessi Qorri, Manpreet Sambi, Justin Jain, Regina-Veronicka Kalaydina, Nicole Mendonza, Komal Bajwa, Myron R Szewczuk
The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome. International journal of molecular sciences 19 (2) (2018)
Bessi Qorri, Regina-Veronicka Kalaydina, Aleksandra Velickovic, Yekatrina Kaplya, Alexandria Decarlo, Myron R Szewczuk
Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling. Cells 7 (9) (2018)